Ignite Creation Date:
2025-12-25 @ 3:02 AM
Ignite Modification Date:
2025-12-30 @ 10:24 PM
Study NCT ID:
NCT00198133
Status:
COMPLETED
Last Update Posted:
2019-07-22
First Post:
2005-09-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma
Sponsor:
Patrick Joseph Loehrer Sr.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
0412-18; IUCRO-0088
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None